Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prevalence of Thrombosis in COVID-Patients in Correlation to Humoral and Cellular Immunity

NCT04615026 is registered in ClinicalTrials.gov with University Hospital Augsburg as lead sponsor.

NCT NCT04615026
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04615026 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prevalence of Thrombosis in COVID-Patients in Correlation to Humoral and Cellular Immunity
Lead sponsor
University Hospital Augsburg
Phase
Observational
Overall status
Completed
Start date
November 4, 2020
Completion date
June 30, 2021
Enrollment
525 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

covid19